Townsquare Capital LLC Has $2.04 Million Stock Holdings in Haleon PLC Sponsored ADR (NYSE:HLN)

Key Points

• Townsquare Capital LLC reduced its holdings in Haleon PLC by 17.7%, selling 42,686 shares, resulting in a total of 198,266 shares worth approximately $2.04 million by the end of the first quarter.
• Haleon recently announced a semi-annual dividend of $0.0555 per share, an increase from the previous $0.05, reflecting a dividend yield of 190.0%.
• The stock currently maintains a market cap of $43.05 billion and a consensus analyst rating of "Moderate Buy," with an average target price of $12.33.

Townsquare Capital LLC cut its position in Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 17.7% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 198,266 shares of the company's stock after selling 42,686 shares during the period. Townsquare Capital LLC's holdings in Haleon were worth $2,040,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Deutsche Bank AG raised its position in Haleon by 267.8% in the 1st quarter. Deutsche Bank AG now owns 3,126 shares of the company's stock valued at $32,000 after buying an additional 2,276 shares during the last quarter. Headlands Technologies LLC acquired a new stake in shares of Haleon in the first quarter valued at approximately $220,000. Charles Schwab Investment Management Inc. raised its holdings in shares of Haleon by 28.8% in the first quarter. Charles Schwab Investment Management Inc. now owns 342,213 shares of the company's stock valued at $3,521,000 after purchasing an additional 76,469 shares during the last quarter. ABC Arbitrage SA bought a new stake in shares of Haleon in the first quarter worth $124,000. Finally, Cary Street Partners Investment Advisory LLC boosted its holdings in Haleon by 1,869.0% during the first quarter. Cary Street Partners Investment Advisory LLC now owns 7,305 shares of the company's stock worth $75,000 after purchasing an additional 6,934 shares during the last quarter. 6.67% of the stock is owned by institutional investors.

Haleon Stock Performance

Shares of HLN stock traded down $0.06 during midday trading on Friday, hitting $9.64. 7,875,929 shares of the company were exchanged, compared to its average volume of 11,052,347. Haleon PLC Sponsored ADR has a 52 week low of $8.86 and a 52 week high of $11.42. The firm has a market capitalization of $43.30 billion, a P/E ratio of 24.72, a PEG ratio of 2.86 and a beta of 0.23. The firm's 50 day moving average price is $10.04 and its two-hundred day moving average price is $10.20. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.63 and a current ratio of 0.87.

Haleon Increases Dividend

The business also recently announced a semi-annual dividend, which will be paid on Thursday, September 18th. Stockholders of record on Friday, August 15th will be given a dividend of $0.0555 per share. This represents a dividend yield of 190.0%. The ex-dividend date is Friday, August 15th. This is a positive change from Haleon's previous semi-annual dividend of $0.05. Haleon's dividend payout ratio is currently 64.10%.

Analyst Ratings Changes

HLN has been the topic of several recent research reports. BNP Paribas Exane upgraded shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price target on the stock in a research note on Tuesday, May 27th. Wall Street Zen downgraded Haleon from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Morgan Stanley upgraded shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 target price for the company in a research note on Friday, May 9th. BNP Paribas upgraded Haleon to a "strong-buy" rating in a report on Tuesday, May 27th. Finally, Barclays restated an "overweight" rating on shares of Haleon in a research note on Tuesday, May 6th. Five equities research analysts have rated the stock with a hold rating, three have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, Haleon has an average rating of "Moderate Buy" and a consensus price target of $12.33.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.